Advertisement
Legal
Subscribe to Legal

The Lead

DuPont Fined $1.3M Over Series of West Virginia Chemical Leaks

August 28, 2014 8:20 am | by JOHN RABY, Associated Press | News | Comments

DuPont will pay a fine of $1.275M to settle a federal complaint over eight chemical releases from a Kanawha County production facility, one of which killed a worker. The Department of Justice and U.S. Environmental Protection Agency said the settlement announced in a statement Wednesday resolves several alleged violations of federal law.

Japan’s Scandal-Hit Stem-Cell Center to Be Downsized

August 27, 2014 9:08 am | Videos | Comments

One of Japan’s leading research institutions, the prestigious Riken Institute, will scale down...

Allergan to Request Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws

August 27, 2014 8:27 am | News | Comments

Allergan has asked the United States District Court for the Central District of California to...

Allergan Reviews Meeting Requests in Takeover Bid

August 23, 2014 2:27 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

Allergan Inc. is reviewing shareholder requests for a special meeting to consider replacing most...

View Sample

FREE Email Newsletter

Business Leery of Alabama Ruling on Drug Warnings

August 23, 2014 11:30 am | by Jay Reeves - Associated Press - Associated Press | News | Comments

Business isn't buying the Alabama Supreme Court's attempt to limit the fallout from its decision saying brand-name drugmakers can be held liable for warnings on generic medication produced by other companies. A majority of justices signed off on an opinion that went to lengths last week to say...

Execution Drug Cost Quadruples for Texas Prisons

August 15, 2014 2:45 pm | by MICHAEL GRACZYK, Associated Press | News | Comments

The prison agency in the nation's busiest death penalty state paid $13,500 for its most recent batch of pentobarbital at a cost of $1,500 per vial, compared to $350 per dose spent last year.           

Turkish Man Pleads Guilty to Importing Illegal Cancer Drugs

August 15, 2014 2:41 pm | News | Comments

Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States.          

Advertisement

Judge Extends Temporary Halt to Ohio Executions

August 12, 2014 8:26 am | by ANDREW WELSH-HUGGINS, AP Legal Affairs Writer | News | Comments

A freeze on capital punishment in Ohio will continue into 2015 after a federal judge extended a months-long moratorium on executions as questions mount about the effectiveness of a new, two-drug combination being used to carry out the death penalty.

Former State AG Testifies in ex-Va. Governor Trial

August 12, 2014 8:12 am | by LARRY O'DELL, Associated Press | News | Comments

The wealthy businessman who lavished former Virginia Gov. Bob McDonnell and his wife with thousands of dollars in gifts and loans said repeatedly that the couple supported his company and its signature product, former state Attorney General Jerry Kilgore testified Monday.

McKesson Settles Tennessee Vaccine Case for $18M

August 11, 2014 8:29 am | News | Comments

McKesson Corp. was required to ensure vaccines were maintained at proper temperatures by, among other things, setting electronic temperature monitors to detect when air temperature in the box reached certain levels.      

AIDS Patients Fear Discrimination in ACA Exchange

August 7, 2014 8:47 am | by KELLI KENNEDY, Associated Press | News | Comments

Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers. While the issue applies broadly to all patients with chronic illnesses that require expensive medication, HIV and AIDS advocates say they were the first to file a formal complaint with the government about pricing.

Mallinckrodt Settles OFIRMEV® Patent Litigation with Fresenius Kabi USA

August 7, 2014 8:40 am | News | Comments

Mallinckrodt today announced that its subsidiary, Cadence Pharmaceuticals, Inc., has entered into settlement and license agreements with Fresenius Kabi USA, LLC, resolving pending patent litigation involving OFIRMEV ® (acetaminophen) injection.

Advertisement

Pfizer to Pay $35M to Settle Drug Marketing Case

August 6, 2014 4:38 pm | by The Associated Press | News | Comments

Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses. The states' attorneys general said Wednesday that Wyeth, which Pfizer bought in 2009, trained sales representatives to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.

China Probes Pharmaceutical Companies, Automakers, Technology Firms

August 6, 2014 8:13 am | by JOE McDONALD, AP Business Writer | News | Comments

Chinese regulators have launched a series of anti-monopoly investigations of foreign automakers and technology providers, stepping up pressure on foreign companies that feel increasingly unwelcome in China.        

Investigators Say Doctor Prescribed Painkillers for Profit

August 4, 2014 9:09 am | Videos | Comments

Federal investigators warn of the growing problem of "dirty doctors," who prescribe highly-addictive painkillers for cash.                      

Allergan Sues Valeant, Claims Fraud in Buy Attempt

August 1, 2014 3:34 pm | by Linda A. Johnson - AP Business Writer - Associated Press | News | Comments

Allergan Inc.'s lawsuit, filed Friday in U.S. District Court in Santa Ana, California, names as plaintiffs drugmaker Valeant Pharmaceuticals International Inc., New York investment and hedge fund firm Pershing Square Capital Management LP and its principal, William Ackerman.

Former Virgina Governor Back in Court

July 31, 2014 11:07 am | Videos | Comments

Bob McDonnell headed back to court Thursday over federal corruption charges alleging that he and his wife accepted more than $165,000 in gifts, lavish trips, and cash in exchange for promoting dietary supplements.                 

Advertisement

Idaho Officials: Prison Takeover Reveals Lack of Inmate Medications

July 29, 2014 8:44 am | by REBECCA BOONE, Associated Press | News | Comments

Idaho prison officials say they had to have thousands of dollars' worth of medications shipped overnight to the state's largest prison after the former operator, Corrections Corporation of America, left the facility without a promised eight-day supply of inmate drugs.

China to Put Glaxo Investigators On Trial

July 29, 2014 5:30 am | by The Associated Press | News | Comments

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens. The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial."

Arizona Execution Renews Debate Over Methods

July 28, 2014 8:14 am | by PAUL ELIAS, Associated Press | News | Comments

A third execution by lethal injection has gone awry in six months, renewing debate over whether there is a foolproof way for the government to humanely kill condemned criminals, and whether it's even worth looking for one.     

Obama Wants Limits on US Company Mergers Abroad

July 25, 2014 8:32 am | News | Comments

Staking out a populist stand ahead of the midterm elections, President Barack Obama on Thursday demanded "economic patriotism" from U.S. corporations that use legal means to avoid U.S. taxes through overseas mergers.      

When Will We Learn?

July 23, 2014 3:11 pm | by Mike Auerbach, Editor In Chief | Blogs | Comments

Humans are a strange lot. We are more than willing to believe just about any product claim in the hopes that an easy solution to our problem can be found inside a pill, tablet or liquid.           

States Sue 5-Hour Energy Over Ad Claims

July 21, 2014 8:35 am | by STEVEN DUBOIS, Associated Press | News | Comments

The Oregon lawsuit filed Thursday in Portland contends 5-Hour Energy falsely claims customers get extra energy and focus from a unique blend of ingredients, when the boost actually comes from a concentrated dose of caffeine.     

China Indicts US, British Nationals Involved In GSK Investigation

July 13, 2014 11:26 pm | by The Associated Press | News | Comments

Chinese authorities formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information, state media reported Monday. Prosecutors in Shanghai filed charges against British investigator Peter Humphrey and his wife Yingzeng Yu, a U.S. citizen, at the city's No. 1 Intermediate People's Court, the official Xinhua News Agency said.

Compounding Pharmacy Oversight Changes Signed

July 11, 2014 8:22 am | News | Comments

Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies.  

Neurelis Regains Rights to Intranasal Diazepam Program

July 11, 2014 8:08 am | News | Comments

Neurelis has announced an agreement with Biotie Therapies to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 for pediatric and adult epilepsy patients who experience acute repetitive seizures.

Hospital Pharmacist Charged in Theft of 200K Pills

July 9, 2014 8:19 am | by JENNIFER PELTZ, Associated Press | News | Comments

A pharmacist who oversaw a major hospital's vault of drugs stole nearly 200,000 powerful painkillers he was supposed to safeguard and dispense, narcotics prosecutors said Tuesday as they unveiled a case that makes unusual use of a state drug-kingpin law.

$580M EU Antitrust Fine for Drug Makers

July 9, 2014 8:14 am | News | Comments

The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.        

US Officials Barred from American's Trial in China

July 4, 2014 5:25 am | by The Associated Press | News | Comments

A U.S. Embassy spokesman says diplomats are barred from the trial in Shanghai of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information. Spokesman Nolan Barkhouse said Friday that the U.S. government is concerned about lack of access to the trial of Yu Yingzeng and husband Peter Humphrey in August.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading